OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
This study has been terminated.
Sponsor:
OHSU Knight Cancer Institute
Collaborator:
Information provided by (Responsible Party):
OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier:
NCT00900302
First received: May 9, 2009
Last updated: May 24, 2012
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | March 2011 |
| Estimated Primary Completion Date: | No date given |